| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | temsirolimus | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | ATRA | GDSC1000 | pan-cancer | AAC | 0.0075 | 0.8 |
| mRNA | Bleomycin | GDSC1000 | pan-cancer | AAC | 0.0076 | 0.8 |
| mRNA | WAY-362450 | CTRPv2 | pan-cancer | AAC | -0.0079 | 0.8 |
| mRNA | GDC-0941 | gCSI | pan-cancer | AAC | 0.013 | 0.8 |
| mRNA | masitinib | CTRPv2 | pan-cancer | AAC | 0.0076 | 0.8 |
| mRNA | IU1 | CTRPv2 | pan-cancer | AAC | 0.008 | 0.9 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | -0.0098 | 0.9 |
| mRNA | PI-103 | CTRPv2 | pan-cancer | AAC | -0.007 | 0.9 |
| mRNA | sotrastaurin | CTRPv2 | pan-cancer | AAC | -0.0078 | 0.9 |